Donor steatosis in the metabolic dysfunction-associated steatotic liver disease era: a retrospective analysis of challenges and outcomes in living donor liver transplantation
In carefully selected donors, mild to moderate hepatic steatosis may not be associated with adverse posttransplant outcomes in LDLT. Incorporating such donors may safely expand the donor pool amid the growing MASLD epidemic. Prospective studies are needed to further refine donor selection criteria.
Authors
- Ruchi Rastogi (ORCID: https://orcid.org/0000-0002-2064-5178)
- Shekhar Singh Jadaun (ORCID: https://orcid.org/0000-0002-8951-933X)
- Sweety Gupta (ORCID: https://orcid.org/0000-0002-3893-2781)
- Phani Kumar Nekarakanti (ORCID: https://orcid.org/0000-0002-4799-2081)
- Peush Sahni
- Dhiraj Agrawal
- Sanjiv Saigal
- Hetal Pampania
- Akshit Awasthi
Institutions
- Max Super Speciality Hospital (IN)
Publication Details
- Journal
- Clinical Transplantation and Research
- Published
- 2026-03-12
- DOI
- https://doi.org/10.4285/ctr.25.0072
- Primary Topic
- Organ Transplantation Techniques and Outcomes
- Type
- article
- Field-Weighted Citation Impact
- 0.00